 Kristi Anseth
Concepts (708)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 167 | 2026 | 706 | 26.860 |
Why?
| | Polyethylene Glycols | 123 | 2026 | 649 | 17.670 |
Why?
| | Biocompatible Materials | 85 | 2025 | 432 | 11.410 |
Why?
| | Extracellular Matrix | 61 | 2026 | 566 | 9.570 |
Why?
| | Tissue Engineering | 56 | 2023 | 439 | 7.260 |
Why?
| | Myofibroblasts | 19 | 2025 | 149 | 6.570 |
Why?
| | Cell Culture Techniques | 34 | 2023 | 375 | 5.850 |
Why?
| | Aortic Valve | 25 | 2025 | 364 | 5.800 |
Why?
| | Organoids | 10 | 2026 | 146 | 4.840 |
Why?
| | Chondrocytes | 24 | 2021 | 232 | 4.730 |
Why?
| | Polymers | 47 | 2024 | 486 | 4.570 |
Why?
| | Mechanotransduction, Cellular | 12 | 2026 | 121 | 4.490 |
Why?
| | Elasticity | 19 | 2024 | 189 | 4.480 |
Why?
| | Heart Valves | 14 | 2019 | 44 | 4.320 |
Why?
| | Sulfhydryl Compounds | 20 | 2025 | 189 | 4.280 |
Why?
| | Calcinosis | 12 | 2025 | 234 | 4.030 |
Why?
| | Cells, Cultured | 80 | 2025 | 4169 | 3.990 |
Why?
| | Aortic Valve Stenosis | 10 | 2025 | 256 | 3.830 |
Why?
| | Fibroblasts | 21 | 2025 | 1039 | 3.820 |
Why?
| | Cell Differentiation | 36 | 2026 | 2054 | 3.710 |
Why?
| | Cross-Linking Reagents | 35 | 2025 | 207 | 3.640 |
Why?
| | Osteogenesis | 15 | 2020 | 205 | 3.060 |
Why?
| | Oligopeptides | 19 | 2024 | 267 | 3.030 |
Why?
| | Intestines | 6 | 2026 | 356 | 2.920 |
Why?
| | Hydrazones | 7 | 2024 | 26 | 2.880 |
Why?
| | Tissue Scaffolds | 18 | 2024 | 221 | 2.870 |
Why?
| | Cell Survival | 37 | 2024 | 1111 | 2.710 |
Why?
| | Photochemistry | 34 | 2021 | 127 | 2.620 |
Why?
| | Click Chemistry | 10 | 2021 | 54 | 2.610 |
Why?
| | Swine | 35 | 2022 | 828 | 2.600 |
Why?
| | Osteoblasts | 14 | 2025 | 146 | 2.520 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 17 | 2016 | 80 | 2.510 |
Why?
| | Animals | 145 | 2026 | 38410 | 2.400 |
Why?
| | Biomimetic Materials | 11 | 2018 | 78 | 2.360 |
Why?
| | Light | 23 | 2026 | 403 | 2.310 |
Why?
| | Photolysis | 10 | 2025 | 90 | 2.150 |
Why?
| | Cellular Microenvironment | 7 | 2022 | 94 | 2.120 |
Why?
| | Peptides | 15 | 2015 | 1003 | 1.920 |
Why?
| | Materials Testing | 34 | 2019 | 346 | 1.920 |
Why?
| | Cartilage | 13 | 2018 | 198 | 1.920 |
Why?
| | Drug Delivery Systems | 15 | 2024 | 381 | 1.900 |
Why?
| | Intestinal Mucosa | 7 | 2026 | 676 | 1.870 |
Why?
| | Cell Adhesion | 23 | 2026 | 451 | 1.870 |
Why?
| | Photochemical Processes | 13 | 2024 | 103 | 1.780 |
Why?
| | Cell Movement | 11 | 2024 | 966 | 1.770 |
Why?
| | Transforming Growth Factor beta1 | 12 | 2020 | 177 | 1.690 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2024 | 212 | 1.660 |
Why?
| | Cell Communication | 10 | 2016 | 329 | 1.660 |
Why?
| | Acrylic Resins | 3 | 2025 | 48 | 1.640 |
Why?
| | Proteins | 7 | 2023 | 1024 | 1.600 |
Why?
| | Matrix Metalloproteinases | 9 | 2017 | 95 | 1.590 |
Why?
| | Esters | 6 | 2025 | 71 | 1.590 |
Why?
| | Cartilage, Articular | 8 | 2021 | 349 | 1.500 |
Why?
| | Collagen | 14 | 2021 | 460 | 1.450 |
Why?
| | Actins | 16 | 2022 | 428 | 1.440 |
Why?
| | Insulin-Secreting Cells | 7 | 2014 | 393 | 1.380 |
Why?
| | Microscopy | 2 | 2023 | 148 | 1.330 |
Why?
| | Myoblasts | 6 | 2024 | 83 | 1.280 |
Why?
| | Melanoma | 4 | 2021 | 774 | 1.260 |
Why?
| | Azides | 5 | 2022 | 49 | 1.250 |
Why?
| | Fibrosis | 8 | 2025 | 568 | 1.240 |
Why?
| | Mice | 51 | 2025 | 18491 | 1.220 |
Why?
| | Hyaluronic Acid | 6 | 2024 | 226 | 1.220 |
Why?
| | Molecular Structure | 22 | 2025 | 488 | 1.180 |
Why?
| | Paracrine Communication | 3 | 2020 | 67 | 1.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 7 | 2026 | 430 | 1.150 |
Why?
| | Cells, Immobilized | 7 | 2018 | 20 | 1.140 |
Why?
| | Polymerization | 8 | 2025 | 127 | 1.090 |
Why?
| | Cadherins | 3 | 2022 | 204 | 1.080 |
Why?
| | Humans | 116 | 2026 | 147293 | 1.080 |
Why?
| | Islets of Langerhans | 7 | 2010 | 853 | 1.070 |
Why?
| | Coated Materials, Biocompatible | 5 | 2011 | 65 | 1.050 |
Why?
| | Anhydrides | 8 | 2010 | 19 | 1.040 |
Why?
| | Stem Cells | 4 | 2026 | 630 | 1.040 |
Why?
| | Extracellular Matrix Proteins | 4 | 2013 | 156 | 1.030 |
Why?
| | Signal Transduction | 15 | 2022 | 5272 | 1.030 |
Why?
| | Phenotype | 12 | 2025 | 3216 | 1.030 |
Why?
| | Fibroblast Growth Factor 2 | 5 | 2008 | 94 | 1.020 |
Why?
| | Cell Line | 16 | 2025 | 2832 | 1.020 |
Why?
| | Viscosity | 5 | 2024 | 92 | 1.020 |
Why?
| | Elastic Modulus | 8 | 2017 | 121 | 0.990 |
Why?
| | Cell Proliferation | 21 | 2025 | 2529 | 0.990 |
Why?
| | Gels | 9 | 2008 | 86 | 0.990 |
Why?
| | Serum | 3 | 2022 | 58 | 0.990 |
Why?
| | Capsules | 7 | 2019 | 42 | 0.980 |
Why?
| | Acrylates | 12 | 2025 | 48 | 0.960 |
Why?
| | Spheroids, Cellular | 3 | 2017 | 82 | 0.960 |
Why?
| | Integrins | 3 | 2024 | 90 | 0.950 |
Why?
| | Gene Expression | 9 | 2022 | 1481 | 0.950 |
Why?
| | Transforming Growth Factor beta | 6 | 2024 | 475 | 0.930 |
Why?
| | Sulfides | 4 | 2022 | 92 | 0.910 |
Why?
| | Allyl Compounds | 3 | 2022 | 25 | 0.910 |
Why?
| | Indoles | 4 | 2017 | 510 | 0.910 |
Why?
| | Islets of Langerhans Transplantation | 4 | 2010 | 71 | 0.890 |
Why?
| | Sus scrofa | 6 | 2020 | 66 | 0.890 |
Why?
| | Triazoles | 2 | 2024 | 191 | 0.880 |
Why?
| | Heparin | 6 | 2010 | 249 | 0.870 |
Why?
| | Mechanical Phenomena | 3 | 2019 | 80 | 0.850 |
Why?
| | Staphylococcus epidermidis | 3 | 2010 | 79 | 0.840 |
Why?
| | Kinetics | 21 | 2020 | 1569 | 0.830 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2024 | 35 | 0.830 |
Why?
| | Actomyosin | 1 | 2024 | 20 | 0.830 |
Why?
| | Heart Valve Diseases | 3 | 2014 | 151 | 0.820 |
Why?
| | Vancomycin | 3 | 2010 | 96 | 0.820 |
Why?
| | Rheology | 7 | 2024 | 94 | 0.820 |
Why?
| | Bone Regeneration | 4 | 2020 | 28 | 0.800 |
Why?
| | Collagenases | 3 | 2015 | 22 | 0.800 |
Why?
| | PTEN Phosphohydrolase | 1 | 2025 | 165 | 0.800 |
Why?
| | Regenerative Medicine | 2 | 2017 | 49 | 0.790 |
Why?
| | Polyesters | 6 | 2009 | 76 | 0.770 |
Why?
| | Norbornanes | 3 | 2013 | 15 | 0.770 |
Why?
| | Bone Substitutes | 5 | 2019 | 26 | 0.770 |
Why?
| | Delayed-Action Preparations | 10 | 2018 | 191 | 0.760 |
Why?
| | Sulfonamides | 3 | 2017 | 596 | 0.720 |
Why?
| | Peptide Fragments | 4 | 2013 | 698 | 0.720 |
Why?
| | Alkynes | 5 | 2022 | 67 | 0.720 |
Why?
| | Cattle | 19 | 2018 | 948 | 0.710 |
Why?
| | Genes, X-Linked | 1 | 2022 | 21 | 0.710 |
Why?
| | Podosomes | 1 | 2021 | 4 | 0.710 |
Why?
| | X Chromosome Inactivation | 1 | 2022 | 25 | 0.700 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2022 | 41 | 0.700 |
Why?
| | Rats | 26 | 2022 | 5613 | 0.700 |
Why?
| | Fibronectins | 7 | 2012 | 136 | 0.690 |
Why?
| | Elastomers | 1 | 2021 | 30 | 0.670 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1224 | 0.670 |
Why?
| | Stress, Mechanical | 9 | 2021 | 494 | 0.670 |
Why?
| | NIH 3T3 Cells | 11 | 2020 | 145 | 0.670 |
Why?
| | Myocardium | 6 | 2026 | 947 | 0.670 |
Why?
| | Skull | 5 | 2012 | 164 | 0.660 |
Why?
| | Coculture Techniques | 7 | 2024 | 247 | 0.660 |
Why?
| | Chondrogenesis | 4 | 2011 | 88 | 0.660 |
Why?
| | Dexamethasone | 4 | 2013 | 368 | 0.650 |
Why?
| | Mechanoreceptors | 1 | 2020 | 15 | 0.650 |
Why?
| | Bone and Bones | 5 | 2019 | 322 | 0.640 |
Why?
| | Calcium Signaling | 2 | 2020 | 246 | 0.640 |
Why?
| | Inflammation Mediators | 2 | 2020 | 507 | 0.640 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 109 | 0.620 |
Why?
| | Myocytes, Cardiac | 5 | 2020 | 547 | 0.620 |
Why?
| | Models, Biological | 9 | 2024 | 1772 | 0.610 |
Why?
| | Models, Chemical | 8 | 2009 | 251 | 0.610 |
Why?
| | Fluorescent Dyes | 5 | 2015 | 342 | 0.610 |
Why?
| | Phosphates | 3 | 2012 | 177 | 0.600 |
Why?
| | Regeneration | 4 | 2016 | 198 | 0.600 |
Why?
| | Drug Carriers | 7 | 2017 | 137 | 0.600 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.590 |
Why?
| | Tumor Microenvironment | 4 | 2024 | 748 | 0.590 |
Why?
| | Methacrylates | 6 | 2012 | 119 | 0.580 |
Why?
| | Osteoporosis | 1 | 2022 | 239 | 0.580 |
Why?
| | Proteoglycans | 3 | 2013 | 112 | 0.570 |
Why?
| | Biophysics | 1 | 2019 | 75 | 0.570 |
Why?
| | Azo Compounds | 2 | 2018 | 30 | 0.570 |
Why?
| | Aza Compounds | 1 | 2018 | 12 | 0.560 |
Why?
| | Viscoelastic Substances | 2 | 2020 | 8 | 0.560 |
Why?
| | Cyclooctanes | 1 | 2018 | 6 | 0.560 |
Why?
| | Surface Properties | 12 | 2012 | 386 | 0.560 |
Why?
| | Lactic Acid | 6 | 2016 | 295 | 0.560 |
Why?
| | Peptides, Cyclic | 2 | 2010 | 273 | 0.550 |
Why?
| | Pulmonary Alveoli | 3 | 2017 | 389 | 0.540 |
Why?
| | Alkaline Phosphatase | 8 | 2016 | 145 | 0.530 |
Why?
| | Proto-Oncogene Proteins B-raf | 2 | 2021 | 230 | 0.530 |
Why?
| | Molecular Probes | 1 | 2017 | 33 | 0.520 |
Why?
| | Precision Medicine | 2 | 2022 | 464 | 0.520 |
Why?
| | Transcriptome | 5 | 2022 | 1059 | 0.520 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 154 | 0.510 |
Why?
| | Cell Line, Tumor | 11 | 2024 | 3565 | 0.500 |
Why?
| | Phosphoproteins | 4 | 2026 | 337 | 0.500 |
Why?
| | Apoptosis | 10 | 2017 | 2454 | 0.500 |
Why?
| | Antigens | 3 | 2013 | 348 | 0.490 |
Why?
| | Cycloaddition Reaction | 6 | 2024 | 31 | 0.490 |
Why?
| | Biopolymers | 3 | 2022 | 35 | 0.490 |
Why?
| | DNA | 6 | 2006 | 1444 | 0.490 |
Why?
| | Macromolecular Substances | 3 | 2017 | 216 | 0.480 |
Why?
| | Insulin | 9 | 2014 | 2526 | 0.470 |
Why?
| | Cell Self Renewal | 1 | 2016 | 52 | 0.470 |
Why?
| | Lipase | 2 | 2007 | 76 | 0.470 |
Why?
| | Amino Acid Sequence | 7 | 2015 | 2134 | 0.470 |
Why?
| | Polyvinyl Alcohol | 5 | 2002 | 19 | 0.470 |
Why?
| | Gene Expression Regulation | 8 | 2022 | 2625 | 0.460 |
Why?
| | 3T3 Cells | 5 | 2012 | 157 | 0.460 |
Why?
| | Muscle, Smooth | 4 | 2009 | 153 | 0.450 |
Why?
| | Microspheres | 2 | 2015 | 142 | 0.450 |
Why?
| | Microarray Analysis | 1 | 2015 | 117 | 0.450 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2012 | 77 | 0.440 |
Why?
| | Nanoparticles | 3 | 2018 | 524 | 0.430 |
Why?
| | Boidae | 2 | 2026 | 35 | 0.430 |
Why?
| | Solubility | 5 | 2020 | 240 | 0.420 |
Why?
| | Cell Nucleus | 3 | 2026 | 589 | 0.420 |
Why?
| | Rats, Sprague-Dawley | 11 | 2022 | 2542 | 0.410 |
Why?
| | Phenylurea Compounds | 1 | 2015 | 122 | 0.410 |
Why?
| | Immunohistochemistry | 7 | 2022 | 1730 | 0.410 |
Why?
| | Niacinamide | 1 | 2015 | 104 | 0.410 |
Why?
| | Immobilized Proteins | 1 | 2014 | 10 | 0.410 |
Why?
| | Laminin | 4 | 2025 | 73 | 0.410 |
Why?
| | Microscopy, Confocal | 4 | 2012 | 322 | 0.410 |
Why?
| | Macrophages | 2 | 2020 | 1529 | 0.410 |
Why?
| | Mammals | 3 | 2023 | 286 | 0.400 |
Why?
| | Staphylococcal Infections | 2 | 2009 | 395 | 0.400 |
Why?
| | Factor XIIIa | 1 | 2013 | 6 | 0.400 |
Why?
| | Biochemistry | 1 | 2014 | 36 | 0.400 |
Why?
| | Morphogenesis | 2 | 2026 | 171 | 0.400 |
Why?
| | Cell Engineering | 1 | 2013 | 15 | 0.400 |
Why?
| | Antibodies | 2 | 2006 | 398 | 0.400 |
Why?
| | Prostheses and Implants | 5 | 2009 | 137 | 0.400 |
Why?
| | Serum Albumin, Bovine | 2 | 2018 | 62 | 0.390 |
Why?
| | Microfluidics | 3 | 2010 | 61 | 0.390 |
Why?
| | Protein Kinase Inhibitors | 2 | 2021 | 984 | 0.390 |
Why?
| | Compressive Strength | 5 | 2021 | 72 | 0.380 |
Why?
| | Epithelial Cells | 4 | 2022 | 1141 | 0.380 |
Why?
| | beta Catenin | 1 | 2015 | 254 | 0.370 |
Why?
| | Polystyrenes | 5 | 2014 | 38 | 0.370 |
Why?
| | Cytokines | 1 | 2020 | 2086 | 0.370 |
Why?
| | Nanocapsules | 1 | 2012 | 14 | 0.360 |
Why?
| | Leukocyte Elastase | 2 | 2009 | 75 | 0.360 |
Why?
| | Biomarkers | 5 | 2022 | 4351 | 0.360 |
Why?
| | Orthopedics | 4 | 2007 | 181 | 0.360 |
Why?
| | Microfluidic Analytical Techniques | 4 | 2018 | 79 | 0.360 |
Why?
| | Molecular Weight | 5 | 2014 | 313 | 0.360 |
Why?
| | Time Factors | 14 | 2011 | 7173 | 0.350 |
Why?
| | Muscle Contraction | 3 | 2024 | 429 | 0.350 |
Why?
| | Disease Progression | 3 | 2021 | 2890 | 0.340 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 340 | 0.340 |
Why?
| | Embryonic Stem Cells | 2 | 2014 | 124 | 0.340 |
Why?
| | Cardiomegaly | 2 | 2024 | 175 | 0.330 |
Why?
| | TRPV Cation Channels | 2 | 2022 | 43 | 0.330 |
Why?
| | Metalloporphyrins | 1 | 2011 | 63 | 0.330 |
Why?
| | Awards and Prizes | 1 | 2012 | 72 | 0.330 |
Why?
| | Biomechanical Phenomena | 6 | 2017 | 873 | 0.330 |
Why?
| | Tensile Strength | 5 | 2025 | 98 | 0.330 |
Why?
| | MAP Kinase Signaling System | 3 | 2021 | 308 | 0.330 |
Why?
| | Nerve Net | 1 | 2014 | 288 | 0.330 |
Why?
| | Culture Media | 4 | 2014 | 161 | 0.330 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 980 | 0.330 |
Why?
| | Titanium | 2 | 2010 | 74 | 0.320 |
Why?
| | Superoxides | 1 | 2011 | 199 | 0.320 |
Why?
| | Gelatin | 2 | 2017 | 56 | 0.320 |
Why?
| | Printing, Three-Dimensional | 2 | 2022 | 101 | 0.320 |
Why?
| | Organ Culture Techniques | 1 | 2010 | 154 | 0.320 |
Why?
| | Collagen Type I | 4 | 2020 | 145 | 0.310 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2010 | 17 | 0.310 |
Why?
| | Endothelial Cells | 2 | 2014 | 886 | 0.310 |
Why?
| | Prosthesis-Related Infections | 2 | 2009 | 99 | 0.310 |
Why?
| | Fibrosarcoma | 1 | 2009 | 23 | 0.300 |
Why?
| | fas Receptor | 1 | 2010 | 91 | 0.300 |
Why?
| | Phosphinic Acids | 1 | 2009 | 8 | 0.300 |
Why?
| | Equipment Design | 4 | 2017 | 527 | 0.300 |
Why?
| | Recombinant Proteins | 5 | 2012 | 1371 | 0.300 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 112 | 0.300 |
Why?
| | Cardiomyopathies | 1 | 2013 | 339 | 0.290 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2886 | 0.290 |
Why?
| | Pravastatin | 1 | 2009 | 45 | 0.290 |
Why?
| | Parathyroid Hormone | 2 | 2020 | 118 | 0.290 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 308 | 0.290 |
Why?
| | Plasmids | 4 | 2007 | 373 | 0.290 |
Why?
| | Transcription Factors | 4 | 2021 | 1747 | 0.290 |
Why?
| | Magnetic Resonance Spectroscopy | 7 | 2009 | 627 | 0.290 |
Why?
| | Myofibrils | 2 | 2026 | 53 | 0.290 |
Why?
| | Enzymes | 1 | 2009 | 60 | 0.290 |
Why?
| | Anti-Bacterial Agents | 2 | 2010 | 1940 | 0.280 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2009 | 60 | 0.280 |
Why?
| | Heart Valve Prosthesis | 3 | 2005 | 130 | 0.280 |
Why?
| | Bioprinting | 2 | 2022 | 34 | 0.280 |
Why?
| | Trans-Activators | 3 | 2021 | 398 | 0.280 |
Why?
| | In Vitro Techniques | 5 | 2014 | 1049 | 0.280 |
Why?
| | Sex Characteristics | 3 | 2025 | 799 | 0.280 |
Why?
| | Cell Division | 5 | 2004 | 758 | 0.270 |
Why?
| | Dendritic Cells | 1 | 2012 | 510 | 0.270 |
Why?
| | Polyhydroxyethyl Methacrylate | 3 | 2007 | 10 | 0.270 |
Why?
| | Protein Engineering | 2 | 2008 | 122 | 0.270 |
Why?
| | Heart Defects, Congenital | 2 | 2014 | 941 | 0.270 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2009 | 150 | 0.270 |
Why?
| | Transfection | 5 | 2011 | 930 | 0.270 |
Why?
| | Glucocorticoids | 1 | 2012 | 537 | 0.270 |
Why?
| | Smad Proteins | 1 | 2008 | 42 | 0.270 |
Why?
| | Glucose Oxidase | 4 | 2011 | 25 | 0.270 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 512 | 0.270 |
Why?
| | Microscopy, Electron, Scanning | 7 | 2012 | 196 | 0.270 |
Why?
| | Cytoskeleton | 2 | 2026 | 193 | 0.270 |
Why?
| | Protein Binding | 6 | 2010 | 2249 | 0.270 |
Why?
| | Hemodynamics | 1 | 2013 | 1127 | 0.270 |
Why?
| | T-Lymphocytes | 3 | 2012 | 2017 | 0.260 |
Why?
| | Bone Cements | 2 | 2010 | 39 | 0.260 |
Why?
| | Biofilms | 1 | 2010 | 292 | 0.260 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 708 | 0.260 |
Why?
| | High-Throughput Screening Assays | 2 | 2025 | 178 | 0.260 |
Why?
| | Ultraviolet Rays | 5 | 2009 | 385 | 0.250 |
Why?
| | Anoikis | 1 | 2007 | 31 | 0.250 |
Why?
| | Collagen Type II | 4 | 2009 | 53 | 0.250 |
Why?
| | Glucose | 6 | 2014 | 1051 | 0.250 |
Why?
| | Temperature | 5 | 2013 | 638 | 0.250 |
Why?
| | Shear Strength | 2 | 2020 | 73 | 0.250 |
Why?
| | Growth Substances | 3 | 2003 | 138 | 0.240 |
Why?
| | Aorta | 1 | 2009 | 443 | 0.240 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2006 | 55 | 0.240 |
Why?
| | Adsorption | 4 | 2012 | 154 | 0.240 |
Why?
| | Students | 1 | 2012 | 659 | 0.240 |
Why?
| | Cell Shape | 3 | 2022 | 56 | 0.230 |
Why?
| | Nerve Tissue | 1 | 2005 | 7 | 0.230 |
Why?
| | Biology | 2 | 2017 | 89 | 0.230 |
Why?
| | Vimentin | 1 | 2026 | 54 | 0.230 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 3 | 2014 | 45 | 0.230 |
Why?
| | Extracellular Fluid | 1 | 2005 | 38 | 0.230 |
Why?
| | Porosity | 2 | 2019 | 95 | 0.220 |
Why?
| | Biodegradation, Environmental | 6 | 2003 | 75 | 0.220 |
Why?
| | Staining and Labeling | 3 | 2015 | 153 | 0.220 |
Why?
| | Cell Separation | 2 | 2018 | 306 | 0.220 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 448 | 0.220 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2005 | 17 | 0.220 |
Why?
| | Carbonates | 1 | 2025 | 13 | 0.220 |
Why?
| | Bioprosthesis | 1 | 2005 | 39 | 0.220 |
Why?
| | Chromosomes, Human, Y | 1 | 2025 | 37 | 0.220 |
Why?
| | Calcium | 4 | 2024 | 1197 | 0.220 |
Why?
| | PAX7 Transcription Factor | 1 | 2024 | 13 | 0.220 |
Why?
| | Microscopy, Atomic Force | 3 | 2017 | 129 | 0.220 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 849 | 0.220 |
Why?
| | MicroRNAs | 1 | 2011 | 694 | 0.210 |
Why?
| | Carbamates | 1 | 2025 | 51 | 0.210 |
Why?
| | Polyanhydrides | 1 | 2004 | 2 | 0.210 |
Why?
| | Primary Cell Culture | 3 | 2016 | 173 | 0.210 |
Why?
| | Guided Tissue Regeneration | 1 | 2004 | 13 | 0.210 |
Why?
| | Cell Membrane | 3 | 2013 | 711 | 0.210 |
Why?
| | Vesiculovirus | 1 | 2024 | 17 | 0.210 |
Why?
| | Ultrasonography | 1 | 2008 | 795 | 0.210 |
Why?
| | Anisotropy | 1 | 2024 | 78 | 0.210 |
Why?
| | Diffusion | 4 | 2009 | 120 | 0.210 |
Why?
| | Organophosphates | 1 | 2005 | 179 | 0.200 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 4 | 2010 | 85 | 0.200 |
Why?
| | Cell Transplantation | 1 | 2003 | 39 | 0.200 |
Why?
| | Nitrites | 1 | 2004 | 88 | 0.200 |
Why?
| | Azacitidine | 1 | 2025 | 168 | 0.200 |
Why?
| | Chemistry, Pharmaceutical | 2 | 2017 | 112 | 0.200 |
Why?
| | Microscopy, Fluorescence | 3 | 2012 | 409 | 0.190 |
Why?
| | Aldehydes | 2 | 2014 | 140 | 0.190 |
Why?
| | Drug Design | 3 | 2012 | 177 | 0.190 |
Why?
| | Cell Cycle | 2 | 2019 | 600 | 0.190 |
Why?
| | Endoglin | 2 | 2016 | 19 | 0.190 |
Why?
| | Butadienes | 1 | 2003 | 33 | 0.190 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3448 | 0.190 |
Why?
| | Weight-Bearing | 1 | 2004 | 187 | 0.190 |
Why?
| | Annexin A2 | 1 | 2022 | 15 | 0.190 |
Why?
| | Axons | 2 | 2014 | 206 | 0.190 |
Why?
| | Calcification, Physiologic | 1 | 2002 | 29 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2012 | 2030 | 0.180 |
Why?
| | Mice, Inbred BALB C | 3 | 2010 | 1266 | 0.180 |
Why?
| | Hydrolysis | 5 | 2025 | 197 | 0.180 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 26 | 0.180 |
Why?
| | Particle Size | 4 | 2012 | 382 | 0.180 |
Why?
| | Interstitial Cells of Cajal | 2 | 2019 | 3 | 0.180 |
Why?
| | Receptors, Cell Surface | 3 | 2008 | 373 | 0.180 |
Why?
| | Male | 17 | 2025 | 73950 | 0.180 |
Why?
| | Neurons | 3 | 2010 | 1672 | 0.170 |
Why?
| | Robotics | 1 | 2023 | 90 | 0.170 |
Why?
| | Mice, Nude | 4 | 2015 | 680 | 0.170 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1794 | 0.170 |
Why?
| | Base Sequence | 4 | 2012 | 2175 | 0.170 |
Why?
| | Osteopontin | 3 | 2006 | 37 | 0.170 |
Why?
| | Ovariectomy | 1 | 2022 | 166 | 0.170 |
Why?
| | Sex Factors | 3 | 2022 | 2136 | 0.170 |
Why?
| | Organogenesis | 1 | 2022 | 63 | 0.170 |
Why?
| | Isoelectric Point | 1 | 2021 | 22 | 0.170 |
Why?
| | Glycosaminoglycans | 4 | 2008 | 79 | 0.170 |
Why?
| | Vinculin | 2 | 2013 | 10 | 0.170 |
Why?
| | Temporomandibular Joint | 1 | 2001 | 8 | 0.170 |
Why?
| | Sialoglycoproteins | 3 | 2006 | 157 | 0.170 |
Why?
| | Focal Adhesions | 2 | 2015 | 47 | 0.170 |
Why?
| | Drug Compounding | 4 | 2005 | 107 | 0.160 |
Why?
| | Isoproterenol | 1 | 2021 | 96 | 0.160 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2021 | 58 | 0.160 |
Why?
| | Muramidase | 2 | 2012 | 67 | 0.160 |
Why?
| | Membrane Proteins | 2 | 2020 | 1171 | 0.160 |
Why?
| | THP-1 Cells | 1 | 2020 | 19 | 0.160 |
Why?
| | Secretory Pathway | 1 | 2020 | 8 | 0.160 |
Why?
| | Tricarboxylic Acids | 1 | 2000 | 11 | 0.160 |
Why?
| | Chromatography, Gel | 3 | 2007 | 131 | 0.160 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2025 | 794 | 0.160 |
Why?
| | Bacterial Adhesion | 2 | 2012 | 109 | 0.160 |
Why?
| | Hydroxamic Acids | 1 | 2020 | 95 | 0.160 |
Why?
| | Fluoresceins | 2 | 2012 | 48 | 0.150 |
Why?
| | Viral Proteins | 2 | 2024 | 353 | 0.150 |
Why?
| | Wound Healing | 4 | 2022 | 361 | 0.150 |
Why?
| | Hexanes | 1 | 1999 | 3 | 0.150 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2017 | 133 | 0.150 |
Why?
| | Acetylation | 1 | 2020 | 262 | 0.150 |
Why?
| | DNA Methylation | 1 | 2025 | 722 | 0.150 |
Why?
| | DNA Primers | 3 | 2012 | 505 | 0.150 |
Why?
| | Dicarboxylic Acids | 1 | 1999 | 12 | 0.150 |
Why?
| | Photosensitizing Agents | 1 | 2000 | 42 | 0.150 |
Why?
| | Adipogenesis | 2 | 2011 | 56 | 0.150 |
Why?
| | Boronic Acids | 1 | 2019 | 37 | 0.150 |
Why?
| | Ligands | 2 | 2014 | 675 | 0.150 |
Why?
| | Bone Diseases | 1 | 2019 | 61 | 0.140 |
Why?
| | Free Radicals | 2 | 2025 | 105 | 0.140 |
Why?
| | Antibodies, Immobilized | 1 | 2018 | 2 | 0.140 |
Why?
| | Isomerism | 2 | 2018 | 56 | 0.140 |
Why?
| | Histone Deacetylases | 1 | 2020 | 208 | 0.140 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2020 | 219 | 0.140 |
Why?
| | Receptors, Fibroblast Growth Factor | 2 | 2010 | 71 | 0.140 |
Why?
| | Bioengineering | 1 | 2018 | 20 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 440 | 0.140 |
Why?
| | Phenylacetates | 1 | 2018 | 10 | 0.140 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 80 | 0.140 |
Why?
| | Jurkat Cells | 2 | 2010 | 115 | 0.140 |
Why?
| | Equipment Failure Analysis | 2 | 2017 | 124 | 0.140 |
Why?
| | Gold | 1 | 2019 | 116 | 0.140 |
Why?
| | DNA Ligases | 1 | 2018 | 7 | 0.140 |
Why?
| | Bacteriophage T4 | 1 | 2018 | 17 | 0.140 |
Why?
| | Absorbable Implants | 2 | 2009 | 38 | 0.140 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2018 | 81 | 0.130 |
Why?
| | Chemotaxis | 2 | 2009 | 122 | 0.130 |
Why?
| | beta-Cyclodextrins | 1 | 2018 | 32 | 0.130 |
Why?
| | Heart Diseases | 1 | 2021 | 341 | 0.130 |
Why?
| | Absorption | 2 | 2009 | 60 | 0.130 |
Why?
| | A549 Cells | 1 | 2017 | 75 | 0.130 |
Why?
| | Dendrimers | 1 | 2017 | 21 | 0.130 |
Why?
| | Periodicals as Topic | 2 | 2017 | 211 | 0.130 |
Why?
| | Substrate Specificity | 2 | 2009 | 387 | 0.130 |
Why?
| | Animals, Newborn | 3 | 2006 | 914 | 0.130 |
Why?
| | Heart | 1 | 2021 | 628 | 0.130 |
Why?
| | Biomimetics | 1 | 2017 | 41 | 0.130 |
Why?
| | Female | 13 | 2025 | 80076 | 0.130 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 47 | 0.130 |
Why?
| | Biomedical Engineering | 4 | 2001 | 30 | 0.130 |
Why?
| | Antigens, Neoplasm | 1 | 2018 | 273 | 0.120 |
Why?
| | Enzyme Stability | 2 | 2018 | 74 | 0.120 |
Why?
| | Rubber | 1 | 1996 | 8 | 0.120 |
Why?
| | Culture Media, Serum-Free | 2 | 2007 | 42 | 0.120 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 163 | 0.120 |
Why?
| | Elastin | 2 | 2008 | 78 | 0.120 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2017 | 194 | 0.120 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 499 | 0.120 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2008 | 536 | 0.120 |
Why?
| | Maleimides | 2 | 2013 | 21 | 0.120 |
Why?
| | Furans | 2 | 2013 | 26 | 0.120 |
Why?
| | Models, Theoretical | 4 | 2007 | 563 | 0.110 |
Why?
| | Nanomedicine | 1 | 2016 | 47 | 0.110 |
Why?
| | Composite Resins | 1 | 1996 | 106 | 0.110 |
Why?
| | Stromal Cells | 1 | 2015 | 123 | 0.110 |
Why?
| | Structure-Activity Relationship | 2 | 2009 | 567 | 0.110 |
Why?
| | Medicine | 1 | 2017 | 126 | 0.110 |
Why?
| | Hot Temperature | 1 | 2018 | 396 | 0.110 |
Why?
| | Histones | 1 | 2020 | 672 | 0.110 |
Why?
| | Ethylene Glycols | 3 | 2000 | 17 | 0.110 |
Why?
| | Electrophoresis, Agar Gel | 2 | 2004 | 26 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 459 | 0.100 |
Why?
| | Cell-Matrix Junctions | 1 | 2014 | 2 | 0.100 |
Why?
| | Cytostatic Agents | 1 | 2014 | 6 | 0.100 |
Why?
| | Streptavidin | 1 | 2014 | 15 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4604 | 0.100 |
Why?
| | Computational Biology | 2 | 2022 | 677 | 0.100 |
Why?
| | Glass | 1 | 2014 | 47 | 0.100 |
Why?
| | Benzaldehydes | 1 | 2013 | 11 | 0.100 |
Why?
| | Molecular Mimicry | 1 | 2013 | 36 | 0.100 |
Why?
| | Acyltransferases | 1 | 2014 | 78 | 0.100 |
Why?
| | Basal Metabolism | 1 | 2014 | 59 | 0.100 |
Why?
| | Integrin beta1 | 1 | 2013 | 33 | 0.100 |
Why?
| | CD146 Antigen | 1 | 2013 | 38 | 0.100 |
Why?
| | Cyclization | 2 | 2011 | 22 | 0.100 |
Why?
| | Stage-Specific Embryonic Antigens | 1 | 2013 | 2 | 0.100 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2019 | 180 | 0.100 |
Why?
| | Benzoquinones | 1 | 2014 | 46 | 0.100 |
Why?
| | Biophysical Phenomena | 1 | 2013 | 67 | 0.100 |
Why?
| | Muscle Cells | 1 | 2013 | 41 | 0.100 |
Why?
| | Coloring Agents | 1 | 2013 | 90 | 0.100 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 50 | 0.100 |
Why?
| | Cryoultramicrotomy | 1 | 2013 | 7 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2014 | 203 | 0.100 |
Why?
| | Decanoic Acids | 2 | 2005 | 12 | 0.100 |
Why?
| | Gelatin Sponge, Absorbable | 1 | 2012 | 6 | 0.090 |
Why?
| | Sulfhydryl Reagents | 1 | 2012 | 12 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 337 | 0.090 |
Why?
| | Developmental Biology | 1 | 2012 | 24 | 0.090 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2013 | 117 | 0.090 |
Why?
| | Wnt Proteins | 1 | 2013 | 133 | 0.090 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2012 | 45 | 0.090 |
Why?
| | Ethers | 1 | 2012 | 19 | 0.090 |
Why?
| | Connective Tissue Growth Factor | 1 | 2012 | 29 | 0.090 |
Why?
| | Biofouling | 1 | 2012 | 8 | 0.090 |
Why?
| | Fracture Healing | 1 | 2012 | 92 | 0.090 |
Why?
| | Systems Biology | 1 | 2012 | 68 | 0.090 |
Why?
| | Bone Transplantation | 1 | 2012 | 89 | 0.090 |
Why?
| | Crystallization | 2 | 2009 | 136 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 383 | 0.090 |
Why?
| | Thermodynamics | 1 | 2013 | 420 | 0.080 |
Why?
| | Receptor, EphA5 | 1 | 2011 | 1 | 0.080 |
Why?
| | Ephrin-A5 | 1 | 2011 | 1 | 0.080 |
Why?
| | China | 1 | 2012 | 278 | 0.080 |
Why?
| | Endoplasmic Reticulum | 1 | 2013 | 269 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 889 | 0.080 |
Why?
| | Blotting, Western | 1 | 2013 | 1186 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 376 | 0.080 |
Why?
| | Half-Life | 1 | 2011 | 157 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2013 | 1302 | 0.080 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2011 | 41 | 0.080 |
Why?
| | Biological Availability | 1 | 2011 | 146 | 0.080 |
Why?
| | Surface Plasmon Resonance | 1 | 2011 | 87 | 0.080 |
Why?
| | Cell Physiological Phenomena | 1 | 2010 | 17 | 0.080 |
Why?
| | Heparin Lyase | 1 | 2010 | 5 | 0.080 |
Why?
| | Carbohydrate Sequence | 1 | 2010 | 29 | 0.080 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 21 | 0.080 |
Why?
| | Homeostasis | 1 | 2014 | 651 | 0.080 |
Why?
| | Flow Cytometry | 2 | 2011 | 1172 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 1 | 2013 | 627 | 0.080 |
Why?
| | Copper | 1 | 2011 | 122 | 0.080 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 616 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2012 | 311 | 0.080 |
Why?
| | Foreskin | 1 | 2009 | 5 | 0.080 |
Why?
| | Polymethacrylic Acids | 2 | 2003 | 61 | 0.080 |
Why?
| | Enzyme Assays | 1 | 2009 | 25 | 0.080 |
Why?
| | Ascorbic Acid | 1 | 2011 | 184 | 0.080 |
Why?
| | Decorin | 1 | 2009 | 7 | 0.080 |
Why?
| | Lithium | 1 | 2009 | 40 | 0.070 |
Why?
| | Biochemical Phenomena | 1 | 2009 | 10 | 0.070 |
Why?
| | Cloning, Molecular | 1 | 2010 | 539 | 0.070 |
Why?
| | Keratinocytes | 1 | 2010 | 249 | 0.070 |
Why?
| | Acrylamides | 1 | 2009 | 74 | 0.070 |
Why?
| | Biosensing Techniques | 1 | 2011 | 142 | 0.070 |
Why?
| | Adrenal Glands | 1 | 2009 | 77 | 0.070 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2007 | 144 | 0.070 |
Why?
| | Biotechnology | 1 | 2009 | 45 | 0.070 |
Why?
| | Amino Acid Motifs | 1 | 2009 | 219 | 0.070 |
Why?
| | Fibroblast Growth Factors | 1 | 2010 | 188 | 0.070 |
Why?
| | Culture Techniques | 1 | 2008 | 66 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2218 | 0.070 |
Why?
| | Computer Simulation | 2 | 2013 | 1018 | 0.070 |
Why?
| | Serum Albumin | 1 | 2009 | 147 | 0.070 |
Why?
| | X-Ray Diffraction | 2 | 2005 | 84 | 0.070 |
Why?
| | Cysteine | 1 | 2010 | 211 | 0.070 |
Why?
| | Microchemistry | 1 | 2008 | 19 | 0.070 |
Why?
| | Probability | 1 | 2009 | 309 | 0.070 |
Why?
| | Ultrasonics | 1 | 2008 | 50 | 0.070 |
Why?
| | Integrin alpha5beta1 | 1 | 2008 | 9 | 0.070 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2008 | 25 | 0.070 |
Why?
| | Integrin alphaVbeta3 | 1 | 2008 | 20 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 669 | 0.070 |
Why?
| | Fibrin | 1 | 2008 | 84 | 0.070 |
Why?
| | Microbial Sensitivity Tests | 1 | 2009 | 367 | 0.070 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1140 | 0.070 |
Why?
| | Surface-Active Agents | 1 | 2008 | 98 | 0.070 |
Why?
| | Lasers | 1 | 2008 | 128 | 0.070 |
Why?
| | Proteomics | 2 | 2026 | 1203 | 0.070 |
Why?
| | Drug Stability | 2 | 2005 | 169 | 0.060 |
Why?
| | Aggrecans | 1 | 2007 | 15 | 0.060 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2007 | 23 | 0.060 |
Why?
| | Mitogens | 1 | 2007 | 55 | 0.060 |
Why?
| | Mice, Inbred C57BL | 2 | 2010 | 6041 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2009 | 3952 | 0.060 |
Why?
| | Neoplasms | 1 | 2023 | 2946 | 0.060 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 840 | 0.060 |
Why?
| | Hepatocyte Growth Factor | 1 | 2007 | 33 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 643 | 0.060 |
Why?
| | Surgical Wound Infection | 1 | 2010 | 334 | 0.060 |
Why?
| | Digestion | 1 | 2026 | 15 | 0.060 |
Why?
| | Calorimetry, Differential Scanning | 3 | 2005 | 36 | 0.060 |
Why?
| | Environment | 1 | 2008 | 297 | 0.060 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 49 | 0.060 |
Why?
| | Bioreactors | 1 | 2006 | 50 | 0.060 |
Why?
| | Sarcomeres | 1 | 2026 | 101 | 0.060 |
Why?
| | Water | 1 | 2009 | 452 | 0.060 |
Why?
| | Griseofulvin | 1 | 2005 | 2 | 0.060 |
Why?
| | Tetrazolium Salts | 1 | 2005 | 18 | 0.060 |
Why?
| | Stem Cell Transplantation | 1 | 2007 | 189 | 0.060 |
Why?
| | Nanotechnology | 1 | 2007 | 114 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2007 | 288 | 0.060 |
Why?
| | Calcium Phosphates | 1 | 2005 | 28 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1046 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 2017 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 762 | 0.060 |
Why?
| | X-Ray Microtomography | 2 | 2019 | 114 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 2231 | 0.060 |
Why?
| | Ear, External | 1 | 2005 | 22 | 0.060 |
Why?
| | Facial Bones | 1 | 2005 | 28 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2679 | 0.050 |
Why?
| | Immunoblotting | 1 | 2005 | 296 | 0.050 |
Why?
| | Nasal Septum | 1 | 2005 | 30 | 0.050 |
Why?
| | Thiazoles | 1 | 2005 | 142 | 0.050 |
Why?
| | Cell Count | 1 | 2005 | 321 | 0.050 |
Why?
| | Glucagon | 1 | 2005 | 114 | 0.050 |
Why?
| | Nose | 1 | 2005 | 68 | 0.050 |
Why?
| | Larynx | 1 | 2005 | 56 | 0.050 |
Why?
| | Antigens, CD | 1 | 2008 | 562 | 0.050 |
Why?
| | Stress Fibers | 1 | 2004 | 18 | 0.050 |
Why?
| | Hexuronic Acids | 1 | 2004 | 29 | 0.050 |
Why?
| | Glucuronic Acid | 1 | 2004 | 30 | 0.050 |
Why?
| | MCF-7 Cells | 1 | 2024 | 133 | 0.050 |
Why?
| | Methylation | 1 | 2025 | 242 | 0.050 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2005 | 199 | 0.050 |
Why?
| | Sheep | 1 | 2007 | 879 | 0.050 |
Why?
| | Alginates | 1 | 2004 | 60 | 0.050 |
Why?
| | Cell Size | 1 | 2004 | 94 | 0.050 |
Why?
| | Photography | 1 | 2004 | 120 | 0.050 |
Why?
| | Catalysis | 2 | 2017 | 305 | 0.050 |
Why?
| | Postprandial Period | 1 | 2024 | 115 | 0.050 |
Why?
| | Surgical Flaps | 1 | 2005 | 142 | 0.050 |
Why?
| | Immunity, Innate | 1 | 2009 | 840 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2026 | 480 | 0.050 |
Why?
| | Viral Envelope Proteins | 1 | 2024 | 98 | 0.050 |
Why?
| | Magnetic Phenomena | 1 | 2023 | 10 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1798 | 0.050 |
Why?
| | Trachea | 1 | 2005 | 258 | 0.050 |
Why?
| | Gene Transfer Techniques | 1 | 2004 | 189 | 0.050 |
Why?
| | Cystatin C | 1 | 2022 | 66 | 0.050 |
Why?
| | Oxidation-Reduction | 3 | 2011 | 1077 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 1107 | 0.040 |
Why?
| | Somatomedins | 1 | 2002 | 28 | 0.040 |
Why?
| | Biomarkers, Pharmacological | 1 | 2022 | 26 | 0.040 |
Why?
| | Polyvinyls | 1 | 2002 | 19 | 0.040 |
Why?
| | Glycoproteins | 1 | 2024 | 358 | 0.040 |
Why?
| | Technology, Pharmaceutical | 1 | 2002 | 30 | 0.040 |
Why?
| | Subcutaneous Tissue | 1 | 2002 | 26 | 0.040 |
Why?
| | Injections | 1 | 2002 | 200 | 0.040 |
Why?
| | Paneth Cells | 1 | 2022 | 20 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2022 | 82 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2024 | 745 | 0.040 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2001 | 81 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2003 | 317 | 0.040 |
Why?
| | Cicatrix | 1 | 2022 | 72 | 0.040 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 175 | 0.040 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2001 | 7 | 0.040 |
Why?
| | Receptors, Notch | 1 | 2022 | 91 | 0.040 |
Why?
| | Chlorobenzenes | 1 | 2001 | 18 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2023 | 229 | 0.040 |
Why?
| | Succinimides | 1 | 2001 | 21 | 0.040 |
Why?
| | Femur | 2 | 2019 | 261 | 0.040 |
Why?
| | Nucleic Acid Conformation | 1 | 2004 | 726 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2010 | 6543 | 0.040 |
Why?
| | Polyglycolic Acid | 1 | 2001 | 44 | 0.040 |
Why?
| | Adrenergic beta-Agonists | 1 | 2021 | 92 | 0.040 |
Why?
| | Chromosomes | 1 | 2021 | 106 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 143 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 567 | 0.040 |
Why?
| | Mathematical Computing | 1 | 2000 | 11 | 0.040 |
Why?
| | Fumarates | 1 | 2019 | 10 | 0.040 |
Why?
| | Polypropylenes | 1 | 2019 | 12 | 0.040 |
Why?
| | Gonadal Steroid Hormones | 1 | 2021 | 143 | 0.040 |
Why?
| | Ursidae | 1 | 2019 | 8 | 0.040 |
Why?
| | Lung | 1 | 2013 | 4141 | 0.040 |
Why?
| | Muscles | 1 | 2001 | 330 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2000 | 141 | 0.040 |
Why?
| | Blood Proteins | 1 | 2001 | 239 | 0.040 |
Why?
| | Models, Genetic | 1 | 2022 | 536 | 0.040 |
Why?
| | Intracellular Space | 1 | 2019 | 64 | 0.040 |
Why?
| | Spectrophotometry, Infrared | 1 | 1999 | 54 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2006 | 1514 | 0.040 |
Why?
| | Mitochondria | 1 | 2005 | 1000 | 0.030 |
Why?
| | Lipids | 1 | 2003 | 723 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2024 | 936 | 0.030 |
Why?
| | Zebrafish | 1 | 2023 | 536 | 0.030 |
Why?
| | Drug Liberation | 1 | 2018 | 36 | 0.030 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2018 | 36 | 0.030 |
Why?
| | Inflammation | 1 | 2009 | 2920 | 0.030 |
Why?
| | Prosthesis Implantation | 1 | 1999 | 156 | 0.030 |
Why?
| | Protein Transport | 1 | 2019 | 442 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 891 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2004 | 2812 | 0.030 |
Why?
| | Quality Control | 1 | 1996 | 161 | 0.030 |
Why?
| | Ketanserin | 1 | 1996 | 12 | 0.030 |
Why?
| | Genotype | 1 | 2021 | 1875 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 633 | 0.030 |
Why?
| | Sclerosis | 1 | 2014 | 11 | 0.030 |
Why?
| | Collagen Type III | 1 | 2014 | 15 | 0.030 |
Why?
| | Receptors, Wnt | 1 | 2013 | 2 | 0.030 |
Why?
| | Coatomer Protein | 1 | 2013 | 3 | 0.030 |
Why?
| | ras GTPase-Activating Proteins | 1 | 2013 | 16 | 0.030 |
Why?
| | Wnt-5a Protein | 1 | 2013 | 25 | 0.020 |
Why?
| | Exocytosis | 1 | 2014 | 85 | 0.020 |
Why?
| | Myosins | 1 | 2013 | 132 | 0.020 |
Why?
| | Cell Polarity | 1 | 2013 | 137 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2013 | 172 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 1996 | 499 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2016 | 1147 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 194 | 0.020 |
Why?
| | Myocardial Infarction | 1 | 2019 | 1213 | 0.020 |
Why?
| | Microtubules | 1 | 2013 | 267 | 0.020 |
Why?
| | Ear Cartilage | 1 | 2010 | 4 | 0.020 |
Why?
| | Integrin beta4 | 1 | 2010 | 1 | 0.020 |
Why?
| | Enzymes, Immobilized | 1 | 2011 | 30 | 0.020 |
Why?
| | Skin | 2 | 2010 | 759 | 0.020 |
Why?
| | Algorithms | 1 | 1999 | 1868 | 0.020 |
Why?
| | Keratin-14 | 1 | 2010 | 15 | 0.020 |
Why?
| | Dermis | 1 | 2010 | 33 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1912 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 723 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 330 | 0.020 |
Why?
| | Physical Phenomena | 1 | 2009 | 13 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2012 | 397 | 0.020 |
Why?
| | Dimerization | 2 | 1999 | 189 | 0.020 |
Why?
| | Amino Acids | 1 | 2013 | 519 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 381 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 836 | 0.020 |
Why?
| | Buffers | 1 | 2007 | 56 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2007 | 105 | 0.020 |
Why?
| | Nanocomposites | 1 | 2007 | 14 | 0.020 |
Why?
| | Skull Fractures | 1 | 2007 | 36 | 0.020 |
Why?
| | Protons | 1 | 2007 | 96 | 0.010 |
Why?
| | Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.010 |
Why?
| | Chemical Precipitation | 1 | 2005 | 39 | 0.010 |
Why?
| | Powders | 1 | 2005 | 45 | 0.010 |
Why?
| | Excipients | 1 | 2005 | 55 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2007 | 407 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 11947 | 0.010 |
Why?
| | Solutions | 1 | 2004 | 160 | 0.010 |
Why?
| | DNA Replication | 1 | 2004 | 250 | 0.010 |
Why?
| | Models, Statistical | 1 | 2006 | 677 | 0.010 |
Why?
| | Patella | 1 | 2000 | 30 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1253 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 1999 | 170 | 0.010 |
Why?
| | Adhesiveness | 1 | 1996 | 18 | 0.010 |
Why?
| | Freezing | 1 | 1996 | 84 | 0.010 |
Why?
| | Mucins | 1 | 1996 | 75 | 0.010 |
Why?
|
|
Anseth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|